| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $376.6M | +20.3% |
| Cost of Revenue | $185.6M | +3.3% |
| R&D Expense | $80.3M | -11.6% |
| SG&A Expense | $247.0M | +13.1% |
| Operating Income | -$136.3M | +38.3% |
| Pre-tax Income | -$77.0M | +63.0% |
| Income Tax | $719K | +28.4% |
| Net Income | -$77.7M | +62.8% |
| EPS (Basic) | -$1.30 |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $183.0M | -19.1% |
| Short-term Investments | $49.4M | -1.4% |
| Accounts Receivable | $57.0M | +63.4% |
| Inventory | $28.3M | +17.6% |
| Current Assets | $333.0M | -4.0% |
| Total Assets | $641.9M | +4.5% |
| Current Liabilities | $91.4M | +28.7% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$47.6M | +25.7% |
| Capital Expenditures | $28.0M | +451.7% |
| Investing Cash Flow | -$24.8M | -706.3% |
| Financing Cash Flow | $28.5M | +314.2% |
| Free Cash Flow | -$75.6M | -9.3% |
| +63.9% |
| EPS (Diluted) | -$1.30 | +63.9% |
| Total Liabilities |
| $168.9M |
| +19.3% |
| Stockholders' Equity | $473.0M | +0.1% |